Ongoing monitoring may include follow-up appointments (for example, at 4, 8, and 12 weeks initially to coincide with dose escalation, then every 36 months) to assess: Weight loss progress and tolerability Gastrointestinal side effects and their management Cardiovascular parameters (heart rate, blood pressure) Nutritional adequacy and eating behaviours ADHD symptom control and medication effectiveness Mental health and overall wellbeing Patients should be advised to contact their healthcare provider if they experience: Severe or persistent abdominal pain, with or without vomiting (potential pancreatitis) Signs of dehydration or significant fluid loss Rapid or excessive weight loss Palpitations, chest pain, or shortness of breath Changes in mood or worsening of ADHD symptoms Right upper quadrant pain, fever, or jaundice (potential gallbladder disease) Any concerns about medication interactions Shared decision-making is essential
Liraglutide | BNF NICE
Tirzepatide side effects to monitor The side effect comparison between tirzepatide and semaglutide shows broadly similar profiles with some differences in severity
Weigh Fmoc-Glu-OAllyl (40.9 g, 100.0 mmol) and HOBT (16.2 g, 110.0 mmol) and dissolve them in 150 mL of DMF, add DIC (20.4 mL, 120.0 mmol) under ice bath for activation for 5 min, and add the mixture to the reaction In the column, the reaction was carried out at room temperature for 2 hours
Ung creatine trc khi tp Thi im tt nht ung creatine l trc khi tp 20 - 30 pht
Transplantation of platelet-derived mitochondria alleviates cognitive impairment and mitochondrial dysfunction in db/db mice